
The Invesco RAFI Emerging Markets ETF (the Fund) is designed to mirror the performance of the RAFI Fundamental Select Emerging Markets 350 Index. The Fund typically allocates at least 90% of its total assets to securities found within this Index, including American Depository Receipts (ADRs) and Global Depository Receipts (GDRs) representing those components. The Index identifies the largest companies in emerging markets based on four key fundamental financial criteria: book value, cash flow, sales, and dividends. Companies demonstrating superior fundamental strength are weighted in…
Is PXH's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

The Invesco RAFI Emerging Markets ETF (PXH) made its debut on 09/27/2007, and is a smart beta exchange traded fund that provides broad exposure to the Broad Emerging Market ETFs category of the market.

The Invesco RAFI Emerging Markets ETF (NYSEARCA:PXH) has been one of the quieter income winners of 2026, riding a 34.9% one-year gain while paying out roughly $1.04 per share across calendar 2025.

Making its debut on 09/27/2007, smart beta exchange traded fund Invesco RAFI Emerging Markets ETF (PXH) provides investors broad exposure to the Broad Emerging Market ETFs category of the market.

Axiom Financial Strategies LLC raised its holdings in Invesco RAFI Emerging Markets ETF (NYSEARCA:PXH) by 84.0% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 273,688 shares of the company's stock after buying an additional 124,974 shares during the quarter. Invesco RAFI

Invesco RAFI Emerging Markets ETF offers diversified exposure to about 350 emerging market stocks using a fundamental size methodology. PXH trades at significantly lower valuation multiples than EEM, with a 4% yield, but carries heightened geopolitical risk due to 58% exposure to China and Taiwan. PXH has marginally outperformed EEM since inception and has been competitive with FNDE and DFEV since 2022, though recent 12-month returns lag EEM.